Disclosed is a novel compound acting as a cannabinoid receptor 1 inhibitor, the compound being a pyrazolo[1,5-a]pyrimidine derivative, a prodrug thereof, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solvate thereof. The novel compound or the like is useful for preventing or treating diseases mediated by the cannabinoid receptor-1.
本发明涉及一种新型化合物,作为
大麻素受体1
抑制剂,该化合物为
吡唑并[1,5-a]
嘧啶衍
生物,其前药、异构体、药学上可接受的盐、
水合物或溶剂化合物。该新型化合物或类似物可用于预防或治疗由
大麻素受体1介导的疾病。